Latest Divalproex Sodium Stories
Lupin Pharmaceuticals has received final approval for its abbreviated new drug application for divalproex sodium delayed-release tablets, 125mg, 250mg and 500mg from the FDA. Commercial shipments of the product have already commenced.
The U.S. Food and Drug Administration has approved the first generic versions of a drug designed to treat seizures, bipolar disorders and migraine headaches.
- A person in a secondary role, specifically the second most important character (after the protagonist).